Boyu Du

751 total citations
28 papers, 486 citations indexed

About

Boyu Du is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Boyu Du has authored 28 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Boyu Du's work include Immune Cell Function and Interaction (5 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (3 papers). Boyu Du is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (3 papers). Boyu Du collaborates with scholars based in China and Canada. Boyu Du's co-authors include Xueyan Xi, Laifu Zhong, Liping Jiang, Yang Guo, Lan Jin, Chen Yun-he, Xinyi Shi, Dan Cheng, Yujing Gao and Min Zhu and has published in prestigious journals such as Nature Communications, Frontiers in Microbiology and Gene.

In The Last Decade

Boyu Du

28 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boyu Du China	11	193	87	76	68	53	28	486
Jinxin Li China	16	220 1.1×	23 0.3×	81 1.1×	61 0.9×	34 0.6×	67	775
Jilai Tian China	16	245 1.3×	46 0.5×	102 1.3×	66 1.0×	18 0.3×	32	720
Mohsen Alipour Iran	16	392 2.0×	46 0.5×	77 1.0×	43 0.6×	12 0.2×	30	759
Qin Tian China	9	212 1.1×	42 0.5×	44 0.6×	22 0.3×	13 0.2×	19	530
Mohammad Rahmati Yamchi Iran	6	219 1.1×	82 0.9×	57 0.8×	40 0.6×	8 0.2×	7	635
Alin Moldovan Romania	13	205 1.1×	49 0.6×	39 0.5×	25 0.4×	32 0.6×	22	551
Sui Li-hua China	12	357 1.8×	31 0.4×	78 1.0×	61 0.9×	15 0.3×	24	812
Peng Ji China	13	168 0.9×	32 0.4×	80 1.1×	18 0.3×	31 0.6×	27	625
Jian Zhong China	10	177 0.9×	14 0.2×	40 0.5×	46 0.7×	19 0.4×	12	445

Countries citing papers authored by Boyu Du

Since Specialization

Citations

This map shows the geographic impact of Boyu Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyu Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyu Du more than expected).

Fields of papers citing papers by Boyu Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyu Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyu Du. The network helps show where Boyu Du may publish in the future.

Co-authorship network of co-authors of Boyu Du

This figure shows the co-authorship network connecting the top 25 collaborators of Boyu Du. A scholar is included among the top collaborators of Boyu Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyu Du. Boyu Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Zhong, et al.. (2024). Polyphyllin VII as a potential medication for targeting epithelial mesenchymal transitionin in thyroid cancer. Journal of Pharmacological Sciences. 156(2). 49–56. 2 indexed citations

Wu, Qiong, Yangyang Liu, Boyu Du, et al.. (2024). Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling pathways. Inflammopharmacology. 32(1). 849–861. 4 indexed citations

Zhu, Min, Ruihong Yu, Yirui Liu, et al.. (2024). LncRNA H19 Participates in Leukemia Inhibitory Factor Mediated Stemness Promotion in Colorectal Cancer Cells. Biochemical Genetics. 62(5). 3695–3708. 1 indexed citations

Deng, Ting, et al.. (2023). MCP‐1/CCR2 axis is involved in the regulation of γδT cells in lupus nephritis. Scandinavian Journal of Immunology. 98(4). e13305–e13305. 1 indexed citations

Du, Boyu, Ruihong Yu, Yulin Li, et al.. (2023). The function of MSP-activated γδT cells in hepatocellular carcinoma. International Immunopharmacology. 124(Pt A). 110893–110893. 2 indexed citations

Qiu, Fen, Fan Xu, Qingqing Yu, et al.. (2023). Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells. Gene. 892. 147896–147896. 1 indexed citations

Du, Boyu, et al.. (2023). Emodin is a Potential Drug Targeting CD44-positive HepatocellularCancer. Current Cancer Drug Targets. 24(5). 510–518. 6 indexed citations

Chen, Ling, et al.. (2023). Necroptosis in the pathophysiology of preeclampsia. Cell Cycle. 22(14-16). 1713–1725. 11 indexed citations

Wang, Shenghua, Dake Zhang, Wu Wang, et al.. (2022). Grave-to-cradle upcycling of Ni from electroplating wastewater to photothermal CO2 catalysis. Nature Communications. 13(1). 5305–5305. 69 indexed citations

10.

Fu, Fei, Zhongyu Wang, Fen Qiu, et al.. (2022). Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells. Current Cancer Drug Targets. 22(5). 426–435. 7 indexed citations

11.

Du, Boyu, et al.. (2022). Non-structure protein ORF1ab (NSP8) in SARS-CoV-2 contains potential γδT cell epitopes. Frontiers in Microbiology. 13. 936272–936272. 3 indexed citations

12.

Xi, Xueyan, Yang Guo, Min Zhu, et al.. (2021). Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling. Virology Journal. 18(1). 12–12. 22 indexed citations

13.

Xi, Xueyan, Yang Guo, Min Zhu, et al.. (2021). Identification of new potential antigen recognized by γδT cells in hepatocellular carcinoma. Cancer Immunology Immunotherapy. 70(7). 1917–1927. 8 indexed citations

14.

Jin, Lan, Chen Yun-he, Dan Cheng, et al.. (2021). YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression. Cell Death and Disease. 12(5). 457–457. 84 indexed citations

15.

Zhu, Min, et al.. (2020). IFI27 as a potential indicator for severe Enterovirus 71-infected hand foot and mouth disease. Virus Research. 289. 198149–198149. 8 indexed citations

16.

Xu, Fan, Min Zhu, Fen Qiu, et al.. (2020). Curcumin may be a potential adjuvant treatment drug for colon cancer by targeting CD44. International Immunopharmacology. 88. 106991–106991. 23 indexed citations

17.

Du, Boyu, et al.. (2020). Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis. International Immunopharmacology. 80. 106139–106139. 9 indexed citations

18.

Hao, Ling, Boyu Du, & Xueyan Xi. (2017). TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis. Oncology Letters. 14(2). 2153–2164. 20 indexed citations

19.

Xi, Xueyan, Xiaolu Li, Fan Wu, et al.. (2017). Expression, purification and characterization of active untagged recombinant human leukemia inhibitory factor from E.coli. Protein Expression and Purification. 134. 139–146. 8 indexed citations

20.

Du, Boyu, et al.. (2005). Synergistic Inhibitory Effects of Curcumin and 5-Fluorouracil on the Growth of the Human Colon Cancer Cell Line HT-29. Chemotherapy. 52(1). 23–28. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact